We observed a significant higher frequency of subjects having promoter methylation signals at the four genes, RARB (94.0%), CADM1 (76.5%), DAPK1 (64.1%), and PAX1 (96.5%), in patients with invasive cervical cancer compared to the subjects without cancer (Table 2). The gene discussed is PAX1; the disease is cervical cancer.